For example, lncRNA HULC and RHPN1-AS1 have been shown to regulate autophagy and influence therapy resistance in prostate cancer through their interactions with mTOR and EGFR signaling, respectively. This evidence concerns the gene RHPN1 and prostate carcinoma.